The federal appellate court rejected an out-of-state employee's Minnesota Human Rights Act claims against her former ...

The Maine Principal's Association released a statement addressing scrutiny toward its president and its refusal to ban trans ...

12-month roll-out begins today for the biggest regulatory shake up of clinical trials in 20 years ...

First-ever MHRA analysis of UK clinical trial applications finds new opportunities to drive medical breakthroughs for patients: United Kingdom Friday, April 11, 2025, 18:00 Hrs [I ...

The UK's advertising watchdog is cracking down on advertisements for prescription-only weight-loss medication. The ...

It has published a joint Enforcement Notice with the Medicines and Healthcare products Regulatory Agency (MHRA) and General Pharmaceutical Council (GPhC), making clear that ads for named weight-loss ...

Landlords operating unlicensed Airbnb rentals in Malta are under increased scrutiny. During Il-Każin, a discussion programme hosted by Jon Mallia, Tourism Minister Ian Borg said there had been a ...

The UK regulator has been redesignated as one of the WHO’s collaborating centres for the standardisation and evaluation of ...

In 2023, a report by Lord James O’Shaughnessy found the UK had dropped from fourth to tenth as global contributors to clinical trials.

Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025 ISELIN, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc.

Giulio Cossu, MD, University of Manchester, discusses barriers to gene therapy research and development.